BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 3095772)

  • 1. [In-vivo bacteriostatic and bactericidal activity of pefloxacine].
    Meyran M; Thabaut A
    Pathol Biol (Paris); 1986 May; 34(5):349-52. PubMed ID: 3095772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Study of the sensitivity to pipemidic acid, pefloxacin and norfloxacin of 444 bacterial strains isolated at a general hospital].
    Berardi-Grassias LD; Roy O
    Pathol Biol (Paris); 1987 May; 35(5):467-72. PubMed ID: 3112705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparative bacteriologic activity of norfloxacin, ofloxacin and pefloxacin against 320 Gram-negative bacilli resistant and non-resistant to nalidixic acid and cephalosporins].
    Croize J; Le Noc P; Bryskier A; Robert J
    Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):564-8. PubMed ID: 3937128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [In vitro study of the pefloxacine-ceftriaxone combination against 18 strains of Acinetobacter].
    Berardi-Grassias L; Bigel ML; Macheboeuf F; Boisivon A; Chauvière P; Guiomar C
    Pathol Biol (Paris); 1986 May; 34(5):436-9. PubMed ID: 3534716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bactericidal activity and killing rate of serum from volunteers receiving pefloxacin alone or in combination with amikacin.
    Van der Auwera P; Klastersky J; Lieppe S; Husson M; Lauzon D; Lopez AP
    Antimicrob Agents Chemother; 1986 Feb; 29(2):230-4. PubMed ID: 3087276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibacterial activity after a single-dose of norfloxacin, ofloxacin and pipemidic acid detected in urine of volunteers.
    Cruciani M; Monzillo V; Navarra A; Tinelli C; Concia E
    Drugs Exp Clin Res; 1988; 14(8):533-7. PubMed ID: 3150350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activity of fosfomycin combined with rifampin, pefloxacin and imipenem against staphylococci: a study by the time-kill curve method.
    Quentin C; Saivin S; Lafferriere C; Noury P; Bebear C
    Drugs Exp Clin Res; 1987; 13(4):219-24. PubMed ID: 3476291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [In vitro antibacterial activity of piperacillin/quinolone combinations].
    Soussy CJ; Leclercq R; Duval J
    Pathol Biol (Paris); 1988 May; 36(5):357-60. PubMed ID: 3136421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pefloxacin: clinical experience].
    Bertrand A; Janbon F; Jourdan J; Jonquet O; Santoni A
    Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):596-9. PubMed ID: 3937133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bactericidal activity and killing rate of serum in volunteers receiving pefloxacin alone or in combination with ceftazidime, piperacillin or mezlocillin against Pseudomonas aeruginosa.
    Van der Auwera P; Husson M; Klastersky J
    J Antimicrob Chemother; 1988 Jan; 21(1):49-55. PubMed ID: 3128521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of norfloxacin on the faecal flora in patients with complicated urinary tract infections.
    Boerema JB; Olthof BJ; van Saene HK
    Scand J Infect Dis Suppl; 1986; 48():27-31. PubMed ID: 3095916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antibacterial activity of urine after administration of ofloxacin for 5 days].
    Drugeon H; Veyries ML; Levacher M; Garnier M; Aymard G; Giroud JP; Rouveix B
    Therapie; 2000; 55(6):691-7. PubMed ID: 11234464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urine bactericidal activity of pefloxacin versus norfloxacin in healthy female volunteers after a single 800-mg oral dose.
    Hofbauer H; Naber KG; Kinzig-Schippers M; Sörgel F; Rustige-Wiedemann C; Wiedemann B; Reiz A; Kresken M
    Infection; 1997; 25(2):121-6. PubMed ID: 9108190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bacteriostatic activities in normal human serum against serologically classified Pseudomonas as aeruginosa from the urinary tract infection.
    Fujimura N; Yokoyama R
    Tokushima J Exp Med; 1978 Dec; 25(3-4):87-90. PubMed ID: 111374
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical studies of norfloxacin in urinary tract infections].
    Matsuura T; Kurita T
    Hinyokika Kiyo; 1985 Nov; 31(11):2085-9. PubMed ID: 4091145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [In vitro action of fosfomycin combined with rifampicin, pefloxacin and imipenem on staphylococci (checkerboard method in a liquid medium)].
    Quentin C; Noury P; Laurent C; Saivin S; Bebear C
    Pathol Biol (Paris); 1987 Feb; 35(2):153-7. PubMed ID: 3550623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bactericidal effects of norfloxacin towards bacteria in urine.
    Lacey RW; Lord VL; Howson GL
    J Antimicrob Chemother; 1984 May; 13 Suppl B():49-54. PubMed ID: 6234275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro susceptibility of methicillin-resistant Staphylococcus aureus to imipenem and other antimicrobial agents.
    Ishag AJ; Durgham SM; Shibl AM
    Chemioterapia; 1987 Aug; 6(4):261-3. PubMed ID: 3477333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity of pefloxacin compared with five other quinolones on nalidixic acid-resistant proteae species.
    Piccolomini R; Cellini L; Allocati N; Di Girolamo A; Selan L; Scazzocchio F
    Chemioterapia; 1988 Oct; 7(5):287-91. PubMed ID: 3224396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ofloxacin: antibacterial activity, induction of resistance and killing curves.
    Husson MO; Izard D; Bryskier A; Leclerc H
    Chemioterapia; 1985 Aug; 4(4):278-83. PubMed ID: 3863716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.